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The 23S rRNA gene of Coxiella burnetii, the agent of Q fever in humans, contains an unusually high number of
conserved, selfish genetic elements, including two group I introns, termed Cbu.L1917 (L1917) and Cbu.L1951
(L1951). To better understand the role that introns play in Coxiella’s biology, we determined the intrinsic stability
time periods (in vitro half-lives) of the encoded ribozymes to be ⬃15 days for L1917 and ⬃5 days for L1951, possibly
due to differences in their sizes (551 and 1,559 bases, respectively), relative degrees of compactness of the respective
RNA structures, and amounts of single-stranded RNA. In vivo half-lives for both introns were also determined to be
⬃11 min by the use of RNase protection assays and an Escherichia coli model. Intron RNAs were quantified in
synchronous cultures of C. burnetii and found to closely parallel those of 16S rRNA; i.e., ribozyme levels significantly
increased between days 0 and 3 and then remained stable until 8 days postinfection. Both 16S rRNA and ribozyme
levels fell during the stationary and death phases (days 8 to 14). The marked stability of the Coxiella intron RNAs
is presumably conferred by their association with ribosomes, a stoichiometric relationship that was determined to
be one ribozyme, of either type, per 500 ribosomes. Inaccuracies in splicing (exon 2 skipping) were found to increase
during the first 5 days in culture, with a rate of approximately one improperly spliced 23S rRNA per 1.3 million
copies. The in vitro efficiency of L1917 intron splicing was significantly enhanced in the presence of a recombinant
Coxiella RNA DEAD-box helicase (CBU_0670) relative to that of controls, suggesting that this enzyme may serve as
an intron RNA splice facilitator in vivo.
with the 50S ribosome following splicing and inhibit translation
in vitro (19), it is conceivable that the introns are involved in
regulating growth. In fact, analysis of 14-day synchronized infections of Vero cells showed that the quantities of Coxiella
genomes were inversely correlated with the amount of ribozyme present. Collectively, the results suggest that ribozymes modulate the Coxiella growth rate by interfering with
ribosome function and that the inhibition would need to be
alleviated to allow maximal replication. The present study was
undertaken to better define the potential role of introns in
regulating Coxiella growth and development by analyzing the
stability of ribozymes L1917 and L1951 in vitro and in vivo. We
also present data showing 23S rRNA exon 2 skipping that
arises from improper splicing of the two introns and the potential role of RNA helicase (RhlE; CBU_0670) in facilitating
L1917 intron splicing from the precursor 23S rRNA.

Coxiella burnetii is the etiologic agent of Q fever in humans
and one of the most infectious pathogens known (17). The
bacterium also infects domestic ruminants and has been isolated from a variety of other vertebrates and arthropods (7). C.
burnetii is an obligate intracellular parasite in nature that replicates within an acidic, parasitophorous vacuole with many
features of a mature phagolysosome (31). While the Coxiella
intracellular niche provides few opportunities for horizontal
gene transfer, the bacterium’s genome contains an unusually
large number of selfish genetic elements that may have been
acquired during a free-living past. These include dozens of
insertion (IS) elements from eight different families and three
unknown transposases (3, 23), an intein within the C-terminal
region of replicative DNA helicase (DnaB) (19), an intervening sequence (IVS) with a nested open reading frame (ORF)
(CBU_2096) within the single-copy 23S rRNA gene (1), two
highly conserved self-splicing group I introns (Cbu.L1917 and
Cbu.L1951, here termed L1917 and L1951, respectively) that
disrupt the 23S rRNA gene (21), and a homing endonuclease
(HE; CBU_0182) encoded within L1951 (21). Remarkably,
these selfish genetic elements are highly conserved in all eight
genotypes of C. burnetii (21), suggesting that they play adaptive
roles in the pathogen’s biology.
Previous work by our laboratory showed that intron RNAs
(ribozymes) encoded by L1917 and L1951, when heterologously expressed, significantly inhibited the growth of Escherichia coli. Since ribozymes L1917 and L1951 both reassociate

MATERIALS AND METHODS
Bacterial strains, cell lines, and growth conditions. Nine Mile Phase II C.
burnetii (strain RSA 439, clone 4) was propagated in African green monkey
kidney epithelial (Vero) cells (CCL-81; American Type Culture Collection
[ATCC], Manassas, VA), as previously described (19). C. burnetii small-cell
variants (SCVs) were prepared and purified as previously described (19) and
used to inoculate Vero cell monolayers to produce synchronized infections (6).
E. coli strains were grown in Luria-Bertani (LB) medium at 37°C. Kanamycin (50
g/ml) or ampicillin (100 g/ml) was added to the medium as required. JM109
and Top10F⬘ E. coli strains were used for routine cloning and plasmid production. E. coli strain M15 (pREP4) was used as a host to express recombinant RhlE
(rRhlE). A list of the strains and cells used in the study is provided in Table 1.
Nucleic acid purification. Chromosomal DNA was purified using a DNeasy
blood and tissue kit per the instructions of the manufacturer (Qiagen, Valencia,
CA). RNA was purified using a RiboPure Bacteria kit (Ambion, Austin TX) and
subsequently cleaned with an RNeasy kit (Qiagen). Plasmid DNA was prepared
with a QIAprep Spin Miniprep kit (Qiagen). Nucleic acids were quantified by
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TABLE 1. Bacterial strains, cell lines, plasmids and primers used in the study
Designation

Relevant characteristics

Source or reference

Strains
C. burnetii
RSA 439
E. coli
JM109
M15 (pREP4)
Top10F’

Nine Mile Phase II, clone 4

R. A. Heinzen

Host strain for cloning
Host strain for His6 fusion proteins
Host strain for pCR2.1 TOPO constructs

Promega
Qiagen
Invitrogen

Cell line
Vero

Green monkey epithelial line; CCL-81

ATCC

Plasmids
pQE30
pREP4
pCR2.1 TOPO
pUM2
pUM3
pQrhlE

Expression vector for His6 fusion proteins
lacI⫹ in trans repressor plasmid
Cloning vector for PCR products
Cbu.L1917 cloned into pCR2.1 TOPO (Invitrogen)
Cbu.L1951 cloned into pCR2.1 TOPO (Invitrogen)
C. burnetii rhlE cloned into pQE30

Qiagen
Qiagen
Invitrogen
19
19
This study

PCR primers
L1917_flanka
L1917_flank_R
L1951_flank⫹T7P_Fa
L1951_flank_R
L1917_RPA_F
L1917_RPA_Ra
L1951_RPA_F
L1951_RPA_Ra
Cb_rhlE_F
Cb_rhlE_R
Cb_16S_F
Cb_16S_R
Exon_chimera_F
Exon_chimera_R
L1951_internalb
L1951_internalc
L1917_internalb
L1917_internalc

TAATACGACTCACTATAGGGAGGTGGCTGCGACTGTTTAC
GGAATTTCGCTACCTTAGGACCG
TAATACGACTCACTATAGGGTCCTAAGGTAGCGAAATTCC
GTGGAGACAGCGTGGCTATCGTTA
TTTTTTTTTTTTCTTGGCTATATGCTGGAAACTC
TAATACGACTCACTATAGGTTTTTTTTTTTTTCAGGTTTCTTTTGAAAACCCTCT
TTTTTTTTTTTTTCGTAACGACTGATCCGAAAG
TAATACGACTCACTATAGGTTTTTTTTTTTTTTGCCTACGTTTACCTGATGG
AAAAAGGATCCTTGTGTGGCCGGTTTAGGAGT
AAAAAAAGCTTTACTGAGCACTTTATAAATCGTC
CGATCCGTAGCTGGTCTGAGA
ACTGCTGCCTCCCGTAGGA
CGGGCGAAGCTCTTGATC
GGAACTTATAGTTACG
TTTAGCAAAGGGCAATCC
TCCATAGTCACTTACTTCTTG
GGACAATCAGCAGGAAAGAC
CGGACTCTATCATCACACTTA

20
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
19
19
19
19

a

The T7 promoter sequence is underlined.
Forward primer sequence from the indicated reference.
c
Reverse primer sequence from the indicated reference.
b

spectrophotometry at 260 nm. A list of the plasmids and primers used in the
study is provided in Table 1.
In vitro transcription of introns and half-life determination. Introns were
amplified by PCR using C. burnetii genomic DNA and primers (primer pair
L1917_flank and L1917_flank_R or primer pair L1951_flank⫹T7P_F and
L1951_flank_R; Table 1) designed to add a T7 promoter sequence at the 5⬘ end
of the amplicons to create templates for the two ribozymes, as previously described (19). In vitro transcription was done with a MEGAscript kit (Ambion)
following the manufacturer’s instructions, and the resulting RNA was purified
using 5% (wt/vol) acrylamide and an 8 M urea gel (per Ambion technical bulletin
173). Purified RNA was suspended in phosphate-buffered saline (PBS; pH 7.4)
and incubated on days 0 to 9 at 37°C in a capped, RNase-free microcentrifuge
tube. RNA samples were removed at 24-h intervals, quenched with loading buffer
II (Ambion), and stored at ⫺80°C until analyzed. RNA degradation was assessed
by processing RNA samples (250 ng of L1917 and 100 ng of L1951) on ethidium
bromide-stained gels (5% [wt/vol] acrylamide, 8 M urea). Densitometry of ribozyme bands was performed using gel images captured by a GelDoc system
(Bio-Rad; Hercules, CA). RNA half-lives were calculated as ln2/k, where k was
obtained from the equation for the corresponding exponential curve.
In vivo expression of introns and half-life determinations performed using
RPAs. E. coli Top10F⬘ strains harboring pUM2 and pUM3 plasmids were previously described (19) and used to express L1917 and L1951 introns, respectively.
E. coli strains were grown for 16 h in LB broth with ampicillin (LBamp; 100
g/ml) at 37°C with shaking. A 2-ml aliquot of the culture was then used to
inoculate 20 ml of LBamp. Cultures were grown for 2 h at 37°C to an optical

density at 600 nm (OD600) of ⬃0.6, transferred to a 250-ml Erlenmeyer flask, and
grown for an additional hour. IPTG (isopropyl-␤-D-thiogalactopyranoside) was
then added (final concentration, 1 mM), and cultures were allowed to grow for
an additional 2 h. Subsequently, rifampin (Sigma; St. Louis, MO) was added
(final concentration, 160 g/ml), samples (2 ml) were removed at 5-min intervals
for 30 min and centrifuged (10,000 ⫻ g for 1 min), and the pellet was suspended
in 1 ml of Tri reagent (Ambion). Suspensions were stored at ⫺80°C until used.
RNA was purified from the mixture and processed using an RNase protection
assay (RPA) III kit (Ambion) per the instructions of the manufacturer. RPA
reactions were resolved on denaturing gels (5% [wt/vol] acrylamide, 8 M urea)
and then transferred to BrightStar-Plus (Ambion) nylon membranes. Membranes were UV cross-linked using a GS Gene Linker (Bio-Rad) set at 150 mJ.
RPA signals were detected using a nonisotopic BrightStart BioDetect kit (Ambion). RPA probes for the introns were prepared using the corresponding primers (primer pair L1917_RPA_F and L1917_RPA_R or primer pair
L1951_RPA_F and L1951_RPA_R; Table 1) and a MEGAscript kit as instructed, except biotin-labeled UTP (Bio-16-UTP; Ambion) was added to
achieve a final concentration of 0.8 mM. Biotin-labeled RNA probes were subjected to gel purification on acridine orange-stained, 5% (wt/vol) acrylamide–8
M urea gels (per Ambion technical bulletin 173). Final RPA blots were visualized
using an LAS-3000 imaging system (Fujifilm, Stamford, CT).
PCR. Quantitative real-time PCR (qRT-PCR) was done as previously described (19). Primer sets were designed using Beacon Designer 7.5 software
(Biosoft International, Palo Alto, CA) and were specific to the C. burnetii 16S
rRNA-encoding gene (primer pair Cb_16S_F and Cb_16S_R), improperly

5294

HICKS ET AL.

spliced 23S rRNA lacking exon 2 (primer pair Exon_chimera_F and Exon_
chimera_R), and the two introns (primer set L1917_internal and L1951_internal)
(see Table 1 for details). Amplified cDNA was normalized to genome numbers
determined by quantitative PCR (Q-PCR) with a primer set specific to the
Coxiella rpoS gene, as described by Coleman et al. (6). Q-PCR data were also
used to generate Coxiella growth curves, showing genome numbers as a function
of time in infected Vero cell cultures. The qRT-PCR product from improperly
spliced 23S rRNA (i.e., lacking exon 2) was obtained from 6-day-old and 8-dayold Coxiella synchronous cultures. The amplicon was excised from ethidium
bromide-stained, 8% (wt/vol) acrylamide gels, cleaned using a QIAquick nucleotide removal kit (Qiagen), and then cloned into pCR2.1-TOPO (Invitrogen,
Carlsbad, CA) for sequence analysis per the manufacturer’s instructions.
RNA helicase cloning, ATPase, and splicing assays. C. burnetii rhlE
(Cbu_0670) was amplified from chromosomal DNA by PCR using primers with
5⬘-terminal BamHI and HindIII sites (Cb_rhlE_F and Cb_rhlE_R; Table 1) and
standard protocols (2). Amplicons were digested using BamHI and HindIII
restriction endonucleases and cloned into the corresponding sites of pQE30
(Qiagen) by the use of standard protocols (2). The resulting plasmid, pQrhlE,
encodes an in-frame, N-terminal translational fusion associated with the vector’s
His6 tag. E. coli M15 (pREP4) was transformed with pQrhlE (5). A 2-liter culture
of M15 (pREP4 [pQrhlE]) was grown for 2 h in LBamp, induced with IPTG (final
concentration, 1 mM), and incubated for another 2 h. The mixture was centrifuged (4,000 ⫻ g for 20 min at 4°C), and the resulting pellet was frozen (16 h at
⫺20°C). His6-tagged rRhlE was purified from the pellet by the use of nickelnitrilotriacetic acid (Ni-NTA) agarose and native conditions as instructed by the
manufacturer (Qiagen), except the following buffers were used: cell lysis buffer
(20 mM Na2HPO4 [pH 7.4], 500 mM NaCl, 5 mM imidazole); wash buffer (20
mM Na2HPO4 [pH 7.4], 500 mM NaCl, 30 mM imidazole); and elution buffer (20
mM Na2HPO4 [pH 7.4], 500 mM NaCl, 250 mM imidazole). rRhlE was concentrated using a Slide-A-Lyzer dialysis cassette (Thermo Scientific, Waltham, MA)
(3,500 molecular weight cutoff [MWCO]) and TNE buffer (10 mM Tris [pH 8.0],
10 mM NaCl, 1 mM EDTA, 35% [wt/vol] polyethylene glycol [PEG]) (28). rRhlE
ATPase activity was assayed using the general methods of Worrall et al. (33) and
an EnzChek phosphate assay kit per the instructions of the manufacturer (Molecular Probes, Eugene, OR). E. coli tRNA (Sigma) was included in ATPase
assays (final concentration, 40 g/ml). Heat-denatured rRhlE was prepared by
boiling for 10 min and cooling to room temperature prior to use.
The ability of rRhlE to facilitate intron splicing was examined by assaying
intron splicing rates in the presence of 0 or 0.1 M rRhlE or 0.1 M heatdenatured rRhlE, as previously described (20), except 200 M rATP, 10 mCi of
[␥-32P]GTP (Perkin-Elmer, Waltham, MA), and 100 M MgCl2 were used in the
reactions. Intron RNAs were prepared as described for the in vitro half-life
determinations, except L1917 was prepared using alternate primers (i.e.,
L1917_flank and L1951_internal [reverse]; Table 1).
Automated sequence analysis. DNA was routinely verified by sequencing with
an automated DNA sequencer (ABI3130x1) and a BigDye Terminator cycle
sequencing ready-reaction kit (ABI, Foster City, CA). Sequence data were analyzed using Accelrys Gene 2.5 software (Accelrys, San Diego, CA).
Statistical analyses and graphics. At least three independent determinations
were used to calculate means and standard deviations (S.D.) for numerical data.
ImageJ 1.43 software was employed in densitometry. Excel 2010 software (Microsoft, Redmond, WA) was used to generate graphs and statistically analyze
ribozyme half-life curves. Instat software (GraphPad Software, La Jolla, CA) was
used to conduct paired Student’s t tests. A P value ⱕ 0.05 was considered
significant.

RESULTS AND DISCUSSION
Ribozyme half-lives in vitro. Previous work by our laboratory
showed that Coxiella L1917 and L1951 ribozymes (i) associate
with the 50S ribosome, (ii) inhibit translation reactions in vitro,
and (iii) significantly decrease E. coli growth rates when heterologously expressed (19). These results led us to hypothesize
that ribozymes play an adaptive role in Coxiella biology by
slowing the pathogen’s growth rate (⬃11-h generation time)
(6), thereby fostering conditions that promote a persistent,
chronic infection of the host, as previously described (10, 14,
18, 27, 30). However, because ribozymes can be short-lived, the
potential utility of L1917 and L1951 as growth modulators was
unclear. To address this issue, we determined the intrinsic
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stability of Coxiella ribozymes by assaying the RNA half-lives in
vitro. Transcribed and purified L1917 and L1951 ribozymes
were incubated in PBS at 37°C for several days under RNasefree conditions, during which time aliquots of the samples were
taken at 24-h intervals and subsequently analyzed on denaturing acrylamide gels. The results of the experiment showed a
roughly 3-fold difference in the in vitro half-lives of the two
ribozymes, with L1917 exhibiting an ⬃15-day and L1951 an
⬃5-day half-life (Fig. 1). These results suggest that the L1917
ribozyme (551 bases) is intrinsically more stable than L1951
(1,559 bases), at least under the conditions employed in the
assay. It is conceivable that the much smaller size of L1917
allows the formation of a more compact and therefore longerlived RNA structure, especially considering that L1951 contains a 474-base ORF within its P8 helix that encodes a potential LAGLIDADG HE, CBU_0182 (21; LAGLIDADG refers
to a conserved protein motif). A second possibility is that
L1951 has less double-stranded RNA than L1917, making it
more prone to cleavage by an intramolecular phosphoester
transfer mechanism (26).
Ribozyme half-lives in an E. coli model. Previous work suggested the possibility that L1917 might be more labile than
L1951, since L1917 levels were relatively and consistently
lower in C. burnetii cells (19). Because those earlier observations contradict what we observed in vitro (Fig. 1), we assayed
the half-lives of ribozymes L1917 and L1951 in vivo by the use
of RPAs. Initial assays were done using C. burnetii but were
consistently problematic due to low RNA yields and the timing
of sampling in long-term (14-day) synchronized cultures. We
therefore turned to E. coli as a model for the experiment. The
results of the RPAs showed that both L1917 and L1951 demonstrated in vivo half-lives of approximately 11 min in the E.
coli background (Fig. 2). This value is similar to what was
reported for the group I intron of the T4 phage td gene, with
which half-lives for the excised RNA ranged from 12 to 19 min
when expressed in E. coli (4). Since the L1917 and L1951
ribozymes display nearly identical half-lives in vivo, the results
do not help to explain the disparity in ribozyme levels observed
in Coxiella (19) and suggest that there may be limitations to the
model (e.g., RNase activities of E. coli may not be comparable
to those of C. burnetii). RPAs examining the in vivo half-life of
L1917 gave a single RPA signal of ⬃288 bases (Fig. 2A), in
good agreement with the RNA size predicted in silico. However, RPAs used to determine the in vivo half-life of L1951
consistently showed three RPA signals of approximately 533
(full-length RNA), 425, and 230 bases (Fig. 2B). Interestingly,
the ⬃425-base and ⬃230-base bands were also observed in
RPAs prepared with C. burnetii RNA samples (data not
shown) and may represent partial degradation products of the
L1951 ribozyme.
Abundance of ribozymes in synchronized cultures of Coxiella. In a previous report, we quantified ribozyme levels in
Coxiella and normalized them to genome numbers determined
by Q-PCR (19). However, as a result of using this approach,
the relative levels of abundance of ribozymes and rRNAs over
time in culture and the stoichiometry of ribosome inhibition in
vivo could not be determined. To address this lack of information and to help clarify the disparity of ribozyme quantities in
vivo, as mentioned above, long-term synchronized cultures of
C. burnetii were prepared and qRT-PCR was used to quantify
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FIG. 1. In vitro half-lives of L1917 and L1951 ribozymes. (A) Representative example of an in vitro L1917 half-life determination. (Left panel)
An ethidium bromide-stained, 5% (wt/vol) acrylamide–8 M urea gel showing in vitro-transcribed L1917 ribozyme at posttranscription days 0 to 7
(corresponding to column labels). The L1917 band is indicated by an arrowhead; RNA size standards (Ambion) are shown on the left in bases.
(Right panel) Densitometric analysis of the L1917 band versus day of sample collection. The equation for the exponential curve and the R2 value
are inset; the equation yields a half-life of 15.0 days. (B) Representative example of an in vitro L1951 half-life determination. (Left panel) An
ethidium bromide-stained, 5% acrylamide–8 M urea gel showing in vitro-transcribed L1951 ribozyme at posttranscription days 0 to 9 (corresponding to column labels). The L1951 band is indicated by an arrowhead; RNA size standards (Ambion) are given to the left in bases. (Right panel)
Densitometric analysis of the L1951 band versus time of collection. The equation for the exponential curve and the R2 value are inset; the equation
yields a half-life of 5.3 days.

16S, L1917, and L1951 RNAs. Q-PCR was also done to obtain
genome numbers to allow a comparison with our previous
work (19). The results of these experiments showed that, on a
per-genome basis, 16S rRNA levels were highest at day 3 (⬃1.4
million copies per cell), or just as Coxiella log-phase growth
began, and then fell to about 1 million copies per cell at day ⱖ6
postinfection (Fig. 3A). These data are very similar to earlier
quantification results for L1917 and L1951 RNAs determined
on a per-genome basis and led us to conclude that there was an
inverse correlation between levels of ribozyme (per genome)
and Coxiella genome numbers (19). In comparison to the results shown in Fig. 3A, our previous results more likely reflected rapid ribozyme (intron) splicing from the nascent 23S
rRNA precursor, which would be at parity with the 16S rRNA
results, since Coxiella structural RNAs are encoded in a single
operon. When total numbers of 16S rRNA and ribozymes from
1-g Coxiella RNA samples collected over time in culture were
compared, we found that 16S rRNA levels increased significantly over days 0 to 5 (P ⬍ 0.05 for comparisons of the
numbers of RNAs to those determined at the previous collection time) and were stable between day 5 and day 8 (no significant difference; P ⬎ 0.05). Levels of 16S rRNA decreased
significantly over days 8 to 14 (P ⬍ 0.05 for comparisons of the

numbers of RNAs to those determined at the previous collection time), a time period corresponding to the stationary and
death phases. In a fashion similar to the results seen with 16S
rRNA, quantities of L1917 and L1951 ribozymes increased
significantly (P ⬍ 0.05) between days 0 and 3, were stable from
day 3 to day 8 (P ⬎ 0.05), and decreased significantly (P ⬍
0.05) between days 8 and 14 (Fig. 3B). The long-term stability
of both Coxiella ribozymes (Fig. 3B) was a surprising result, as
our earlier report erroneously concluded that ribozyme levels
must fall in order for exponential growth to occur, for the
reasons described above (19). Analysis of the RNA levels determined in this study (Fig. 3B) shows that during the Coxiella
exponential-growth phase (Fig. 3A), there are roughly two
ribozymes (one of each kind) for every thousand ribosomes
(estimated from 16S rRNA results). Those ribozymes may bind
to a ribosome and inhibit translation, as previously demonstrated in E. coli and in vitro, respectively (19).
A second issue arises from the results presented in Fig. 3B.
Although each ribozyme had an in vivo half-life of ⬃11 min
(Fig. 2), quantities of both RNAs remained fairly stable at days
3 to 8 in long-term C. burnetii cultures. Second, although not
always significantly different (P ⬍ 0.05 for day 0 and day 14
samples only), the amounts of L1917 were consistently less
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FIG. 2. In vivo half-lives of L1917 and L1951 ribozymes in E. coli. (A) Representative example of an in vivo L1917 half-life determination by
RPA, as described in the text. (Left panel) RPA blot with the L1917 band (288 bases) indicated with an arrowhead. (The blot was prepared using
500 ng of RNA per lane and 50 pg of L1917 probe.) Lanes: 1, biotin-labeled L1917 probe; 2, as described for lane 1 but including pretreatment
with RNase A/T1 (Ambion); 3 to 9, RNAs isolated at 5-min intervals from 0 to 30 min following rifampin treatment; 10, E. coli RNA. (Right panel)
Densitometric analysis of L1917 bands in lanes 3 to 9 versus time of collection following rifampin treatment. The equation for the exponential curve
and the R2 value are inset; the equation yields a half-life of 11.3 min. (B) Representative example of an in vivo L1951 half-life determination by
RPA, as described in the text. (Left panel) RPA with a full-length L1951 band (533 bases; black arrowhead) plus bands of approximately 425 and
230 bases (indicated by white and gray arrowheads, respectively. (The blot was prepared using 400 ng of RNA per lane and 100 pg of L1951 probe.)
Lanes: 1, biotin-labeled L1951 probe; 2, as described for lane 1 but including pretreatment with RNase A/T1 (Ambion); 3 to 9, RNAs isolated at
5-min intervals from 0 to 30 min following rifampin treatment; 10, E. coli RNA. (Right panel) Densitometric analysis of the L1951 bands in lanes
3 to 9 versus time of collection following rifampin treatment. The equation for the exponential curve and the R2 value are inset; the equation yields
a half-life of 11.1 min.

than those of L1951 regardless of the collection time (Fig. 3B),
as previously observed (19). Long-term stability of the ribozymes may arise from their association with the ribosome
after RNA splicing (19). We previously hypothesized that internal guide sequences (IGSs) were being used by the ribozymes to reassociate with 23S rRNA following splicing (19),
and work by others has shown that RNA stability increases
when a ribozyme binds to a substrate, such as cellular protein
(25). We predict that, prior to association with the ribosome,
L1917 and L1951 stability is dictated by their in vivo half-lives
of ⬃11 min (Fig. 2). Thus, ribozyme levels that were initially on
par with the precursor 23S rRNA levels rapidly fell to roughly
one copy of each ribozyme type for every thousand ribosomes.
Once a ribozyme associates with a ribosome, it becomes very
stable until Coxiella reaches the stationary and death phases
(days 8 to 14; Fig. 3). A lack of parity in ribozyme concentrations (Fig. 3B and reference 19) possibly reflects L1917’s
greater sensitivity to an RNase(s) present in Coxiella but absent in E. coli, for which ribozyme half-lives were not found to
be significantly different (Fig. 2).

Exon skipping during intron splicing in synchronized cultures of Coxiella. Bacteriophage Twort of Staphylococcus aureus encodes three group I introns that disrupt a single phage
gene (ORF142) in a clustering arrangement that resembles
that of the L1917 and L1951 introns of the C. burnetii 23S
rRNA gene. Previous work showed that the Twort introns
exhibited decreased splicing efficiencies during stationaryphase growth of host S. aureus, resulting in ribozyme splice
variants and exon skipping in the mature RNA (13). We were
therefore curious to see whether skipping of the 34-base exon
lying between L1917 and L1951 ([21]; exon 2) occurs during C.
burnetii’s developmental cycle, thereby potentially modulating
translation and growth. To that end, qRT-PCR was done using
RNA collected over the course of 14-day synchronized culture
growth of C. burnetii together with a special primer set (Exon_chimera_F and Exon_chimera_R), where the Exon_chimera_R primer targets an exon 1-exon 3 junction that could arise
only from improper splicing and omission of exon 2. Results of
the experiment showed that quantities of 23S rRNA lacking
exon 2 increased over days 0 to 5 postinfection and then re-
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FIG. 4. 23S rRNA exon 2 skipping during L1917 and L1951 intron
splicing in 14-day synchronized cultures of C. burnetii. qRT-PCR results showing total numbers of 16S rRNAs (black bars) and improperly
spliced 23S rRNAs (exon 2 omitted; diagonally striped bars) present in
1 g of C. burnetii RNA obtained over days 0 to 14 in synchronous
cultures. Data represent the means of the results of six independent
determinations ⫾ S.D.

FIG. 3. Abundance of L1917 and L1951 ribozymes in 14-day synchronized cultures of C. burnetii. (A) Q-PCR and qRT-PCR results
showing quantities of C. burnetii genomes (white bars) and 16S rRNA
per genome (black bars) in millions, respectively, during days 0 to 14
in synchronous cultures. (B) qRT-PCR results showing total numbers
of 16S RNAs (black bars), L1917 RNAs (gray bars), and L1951 RNAs
(white, speckled bars) in 1-g C. burnetii RNA samples obtained over
days 0 to 14 in synchronous cultures. Data represent the means of the
results of six independent determinations ⫾ S.D.

mained at a fairly constant level through day 14 (i.e., no significant difference relative to the day 5 sample). The initial
increase (days 0 to 5) and plateau (days 5 to 14) in improperly
spliced 23S rRNA quantities roughly parallel the 16S rRNA
levels in the samples (Fig. 4), albeit at much lower levels.
Maximal levels (average, 140.9 ⫾ 38.2 copies) of improperly
spliced 23S rRNA were observed on day 5. To ensure that
qRT-PCR results were not due to spurious amplification, we
cloned PCR products of the Exon_chimera primer set from
6-day-old and 8-day-old cultures into pCR2.1-TOPO (Invitrogen). Plasmids from random clones were subsequently purified
and sequenced and were found to contain a 23S rRNA insertion lacking exon 2 (data not shown), verifying the aberrant
splicing event. If 16S and 23S rRNA quantities are assumed to
be equal (since the two rRNAs are encoded in the same,
single-copy operon), these results indicate that improper splicing of 23S rRNA occurs at a rate of about 1 per 1.3 million
copies. Although these results reflect only one possible type of
23S splice variant, they suggest that improper 23S rRNA splicing does not play a significant role in regulating ribosome
quantities in C. burnetii. Interestingly, exon skipping in Coxiella
23S rRNA does not increase during the stationary phase, as
observed in phage Twort introns (13), but rather is highest
during exponential-phase growth, when rRNA transcription is
greatest (see Fig. 3A).
Recombinant RNA helicase (rRhlE) facilitates intron splicing. Although most group I introns, including L1917 and
L1951, are capable of autonomous self-splicing in vitro (21),
the efficiency of splicing is often enhanced in vivo by proteins
that help fold the RNA into a catalytic configuration or disrupt
stable, inactive RNA structures that constitute “kinetic traps”
(11, 12, 32). Bona fide RNA splice facilitators include intron-

encoded HEs (maturases) and host-derived, RNA-dependent
helicases. To investigate the potential involvement of a protein
facilitator in Coxiella intron splicing, we initially focused our
efforts on the potential LAGLIDADG HE carried by L1951
(CBU_0182). However, despite numerous attempts and several alternative strategies, we were unable to clone the HE
gene, possibly owing to its toxicity in E. coli (e.g., a predicted
HE restriction site is present in E. coli 23S rRNA-encoding
genes). We therefore searched the Coxiella genome for potential RNA chaperones that could be involved in splicing and
identified a single, annotated DEAD-box RNA helicase
(RhlE; CBU_0670). DEAD-box RNA helicases are ATP-dependent RNA chaperones in helicase superfamily 2 and are
named for a conserved, Walker B DEAD motif involved in
ATP binding. Functionally, these enzymes use the energy from
ATP hydrolysis to mediate structural rearrangements in substrate RNAs (22, 24, 29). Several reports have demonstrated a
role for DEAD-box RNA helicases in facilitating splicing by
group I and group II introns (8, 9, 15, 16).
Coxiella recombinant RhlE (rRhlE) was generated and
tested for ATPase activity in vitro using an EnzChek phosphate
assay kit (Molecular Probes). Results of the assay showed that
rRhlE has an average ATPase activity of 9.9 ⫾ 2.6 mol of
inorganic phosphate (Pi) released per minute per mole of
enzyme (n ⫽ 4). An example of an assay is shown in Fig. 5A.
Identical ATPase assays that were conducted in the presence
of heat-denatured or 0 M RhlE enzyme did not show an
increase in Pi levels (data not shown), indicating that the recombinant protein was responsible for the observed ATP hydrolysis (Fig. 5A). Having established that rRhlE is an ATPase,
we next wished to determine whether the enzyme was able to
enhance the intron RNA in vitro splicing rate. Results clearly
showed that the L1917 splicing rate was significantly enhanced
(greater slope) in the presence of rRhlE compared to the
control results (P ⬍ 0.05 by paired Student’s t tests versus 0.1
M rRhlE or 0.1 M heat-denatured rRhlE results; Fig. 5B).
In contrast, the difference in the slope values for the two
control treatments was not statistically significant (P ⬎
0.05). These results suggest that splicing of the L1917 intron
may also be enhanced in vivo by splice facilitators, such as
the RNA helicase enzyme. However, the role that RhlE
plays in L1951 intron splicing is still unclear, as splicing
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